Cargando…
Dimethyl fumarate treatment induces lipid metabolism alterations that are linked to immunological changes
OBJECTIVE: Identify metabolic changes produced by dimethyl fumarate (DMF) treatment and link them to immunological effects. METHODS: We enrolled 18 MS patients and obtained blood prior to DMF and 6 months postinitiation. We also enrolled 18 healthy controls for comparison. We performed global metabo...
Autores principales: | Bhargava, Pavan, Fitzgerald, Kathryn C., Venkata, Swarajya L. V., Smith, Matthew D., Kornberg, Michael D., Mowry, Ellen M., Haughey, Norman J., Calabresi, Peter A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331509/ https://www.ncbi.nlm.nih.gov/pubmed/30656182 http://dx.doi.org/10.1002/acn3.676 |
Ejemplares similares
-
Dimethyl fumarate alters B‐cell memory and cytokine production in MS patients
por: Smith, Matthew D., et al.
Publicado: (2017) -
Intermittent calorie restriction alters T cell subsets and metabolic markers in people with multiple sclerosis
por: Fitzgerald, Kathryn C., et al.
Publicado: (2022) -
Immunological Predictors of Dimethyl Fumarate‐Induced Lymphopenia
por: Diebold, Martin, et al.
Publicado: (2022) -
Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism
por: Fitzgerald, Kathryn C., et al.
Publicado: (2021) -
Dimethyl fumarate modulates antioxidant and lipid metabolism in oligodendrocytes
por: Huang, He, et al.
Publicado: (2015)